Daniel Lee is Executive Director of the Levi Strauss Foundation (Chair).
He Joined Levi Strauss & Co. (LS&CO.), and the Levi Strauss Foundation in 2003 as a
Community Affairs Manager for the Asia Pacific Division in Singapore, where he managed and implemented corporate social responsibility programs, employee volunteerism and grantmaking in three global giving areas -- HIV/AIDS, worker rights, and asset building. Subsequently, he relocated to San Francisco and assumed the role of Director of Global Grantmaking Programs. Daniel has extensive experience with international non-governmental organizations in the fields of human rights, HIV/AIDS and social justice.
Before joining LS&Co., he served as Senior Program Officer for Asia and Pacific at the International Gay and Lesbian Human Rights Commission (IGLHRC) and on the founding board of the Massachusetts Asian AIDS Prevention Project. In addition to FCAA, Daniel currently serves on the International Advisory Board of the Astraea Lesbian Foundation for Justice and the Asia-Oceania advisory panel of the Global Fund for Women. He received an AB in Religion and History from Princeton University and a Master of Divinity from Harvard University. Daniel was voted to the Board in November of 2008.
Owen Ryan is Deputy Director, Public Policy, amfAR, The Foundation for AIDS Research.
Prior to amfAR, Owen spent four years working on HIV/AIDS policy and advocacy at the Bill & Melinda Gates Foundation. He has more than 15 years in global health policy and programming experience including work in Malawi, South Africa, and Zimbabwe. Owen earned his Masters of Public Health and of International Affairs from Columbia University. Owen was voted to the board in November of 2009.
Anu Gupta, is Director, Corporate Contributions, Johnson & Johnson (Treasurer).
Anu leads strategic direction and program development efforts worldwide for the HIV/AIDS portfolio. In addition, she oversees the women and children's health portfolio. Previously, Dr. Gupta managed operations and focused on broadening philanthropic activities in the Asia Pacific region. Prior to joining Johnson & Johnson, she served as a consultant to The California Endowment. Dr. Gupta received her MD at the Yale University School of Medicine and completed her residency in internal medicine at Yale-New Haven Hospital where she was also a Robert Wood Johnson Clinical Scholar. Recently married, she lives with her husband Arnab in New York. Anu was voted to the board in October of 2006
J. Channing Wickham is Executive Director of the Washington AIDS Partnership.
Since
1994, Channing Wickham has managed all aspects of the Washington AIDS
Partnership including fundraising, grantmaking, grants management,
program planning, and technical assistance. Channing has extensive
experience in nonprofit management and HIV/AIDS, including as a
trainer/consultant to both nonprofit agencies and corporations in the
Washington, D.C. metropolitan region. Channing has served on the
Mayor’s AIDS Advisory Committee, has chaired the District’s HIV
Prevention Planning Group, has served as both Treasurer and Vice Chair
of the National AIDS Fund, and founded and facilitates the Syringe
Access Working Group. Channing completed his undergraduate work at
Carleton College, and his graduate work at Johns Hopkins University. Channing was voted to the Board in November of 2009.
Scott Campbell is Executive Director of the Elton John AIDS Foundation.
Scott Campbell is a nonprofit executive with over 25 years of experience in relationship building, new market development, media strategies, fund raising, and enhancing the involvement of nonprofit Board members in fund-raising activities. In 1991, Mr. Campbell served as director of development for the National Hemophilia Foundation, maintaining and enhancing fund-raising operations during the devastating impact of the emerging HIV/AIDS epidemic on NHF’s client base. In 1994, Mr. Campbell began his eleven-year association with the American Foundation for AIDS Research (amfAR), rising rapidly in responsibility from senior major gifts officer to director of special campaigns, vice president of development, and finally vice president of institutional development. Mr. Campbell was voted to the Board of Directors in November 2011.
In 2005, Mr. Campbell accepted the call to serve as the Executive Director of the Elton John AIDS Foundation (EJAF). In just two years, Mr. Campbell opened a new EJAF office in New York City, revitalized EJAF’s fund-raising events thereby more than doubling the Foundation’s annual income, and increased its grant-making investments by over 136%. He also spearheaded a strategic review of EJAF’s grant-making program, resulting in new grant-making initiatives targeting prevention programs, services, public messaging, and media outreach for poor communities and marginalized populations across the U.S., the Caribbean, and Latin America.
During the course of his professional career, Mr. Campbell has taken on significant leadership roles as a nonprofit specialist in the field of HIV/AIDS, including his continuing service on the Boards of Trustees of the Elton John AIDS Foundation-UK, AIDS United, and the Caribbean Broadcast Media Partnership on HIV/AIDS.
Alicia L. Carbaugh, is Associate Director, Global Health & HIV Policy
at the Henry J. Kaiser Family
Foundation, a non-profit, private operating foundation. Her work focuses on providing information, research, and analysis on the U.S. government’s role in global health and on the domestic and global HIV epidemics. Ms. Carbaugh also works closely with the Foundation’s media partnerships on HIV in the United States, with entertainment companies and others.
Previously, Ms. Carbaugh served as a policy analyst for the Kaiser Commission on Medicaid and the Uninsured, a major initiative of the Foundation. Her work focused on issues related to health care coverage, access to care, and financing of care for low-income and vulnerable populations. Prior to joining the Foundation in 2003, she served as a senior account executive with Edelman, a global public relations firm, where her work focused on the development and execution of strategic communications initiatives for a range of corporate clients in the health industry.
Ms. Carbaugh holds a Master of Health Science degree in Health Policy from the Johns Hopkins University Bloomberg School of Public Health and graduated with a Bachelor of Arts degree from the College of William and Mary. Alicia was voted to the board in November 2009.
Caitlin L. Chandler serves as Director of the HIV Young Leaders Fund. Caitlin first became involved with youth HIV issues in 2003 through the NYC Student Initiative for AIDS, a youth-run nonprofit raising funds for treatment programs. Caitlin was the Marketing Director and a member of the Board of Directors for the organization. From September 2006 – March 2008, Caitlin was the Capacity-Building Program Officer for the Global Youth Coalition on HIV/AIDS, where she taught GYCA’s e-courses in Project Management, Political Advocacy, and Grantwriting/Fundraising. From March 2008 – December 2009 she worked for aids2031, where she coordinated the 2009 aids2031 Young Leaders Summit in Oslo. She has published writing in different publications; most recently her article “Creating a Different International HIV Response for Young People” appeared in Global Public Health in December 2011. Caitlin spent four months in Accra, Ghana studying abroad and while there volunteered at the West Africa AIDS Foundation, a health clinic and community center for people affected by HIV. She also interned with Médecins Sans Frontières’s Access to Essential Medicines Campaign. Caitlin graduated from New York University with an honors BA in History and Comparative Literature. Caitlin was voted to the Board of Directors in November 2011.
Patricia Doykos, Director of the Bristol-Myers Squibb Foundation.
In the area of HIV/AIDS, Dr. Doykos’s primary role is to mobilize lessons learned from Bristol Myers Squibb's flagship philanthropic program for HIV/AIDS in Africa, Secure the Future, to other regions of the world affected by the epidemic so that they can be replicated and inform evidence-based public health policy and investments. This involves ongoing outreach, advocacy and partnership development with major donors like the President’s Emergency Plan for AIDS Relief (PEPFAR), leading regional, national and community-based non-governmental organizations, governments, schools of public health, professional associations, and corporate philanthropy peers.
Dr. Doykos also has responsibility for global health strategy for the Foundation as a whole and for partnership development and grant making in the areas of serious mental illness in the U.S. and cancer in Europe. These initiatives address health disparities at the community health level by strengthening and integrating healthcare worker capacity (lay/professional) and community mobilization and supportive services for patients and their families.
Dr. Doykos received her B.A. in German and Government from Dartmouth College, M.A. in German Language & Literature from the University of Virginia and doctorate in German Literature & Cultural Studies from New York University. Patricia was voted to the board in July of 2007.
Andrea Flynn is Vice President of the M.A.C AIDS Fund (MAF), the charitable foundation affiliated with M.A.C Cosmetics. Andrea joined MAF in 2007 as Executive Director, International Programs overseeing a grants portfolio of $10-15 million USD annually across the APAC, EMEA and LATAM regions. As Vice President, Andrea currently plays a key role in the M.A.C AIDS Fund’s senior leadership team supporting the Fund’s Global Executive Director and Senior Vice President in the development and execution of its global grant-making and communications strategy and management of the Fund’s finances and day-to-day operations. Currently, the Fund gives away over $25 million annually particularly in the 65 countries in which the company has affiliate businesses.
Prior to joining MAF, Andrea directed global health programs for the Advisory Board Foundation (ABF), a private operating foundation in Washington DC. During her five years with ABF, Andrea oversaw the Foundation’s healthcare partnerships in the United States, the Philippines and Russia as well as its HIV/AIDS programs in South Africa. Andrea has also served as a consultant to the Africa Grantmakers’ Affinity Group and worked with the William J. Clinton Foundation HIV/AIDS Initiative in the Caribbean. She began her career as a clinical social worker at Cancer Care Inc. and Children’s Hospital, Boston specializing in counseling for terminally ill patients and their families, crisis intervention, and bereavement counseling.
Andrea received her Master’s in Business Administration from New York University’s Stern School of Business with concentrations in strategy and multinational business management. She also obtained her Master’s in Clinical Social Work from the Boston College Graduate School of Social Work and graduated cum laude with a bachelor’s degree in psychology from The College of the Holy Cross. Since 2007, Andrea has served as a member of the Steering Committee of the Africa Grantmakers’ Affinity Group. She is also a member of the Estee Lauder Advisory Committee to the Young Women’s Leadership Academy for Girls in Harlem where she is a volunteer. Andrea was voted to the Board of Directors in November 2011.
Melanie Havelin, is the Executive Director of the John M. Lloyd Foundation.
The Los Angeles-based foundation is committed to identifying, understanding and impacting the root causes of the growing worldwide HIV/AIDS crisis. The foundation funds innovative programs throughout the world in public policy, broad-based education/awareness for those infected with or at risk for HIV, leadership development and networking among organizations fighting the pandemic. With assets of $9 million, the Foundation annually awards grants totaling around $450,000.
Before joining the John M. Lloyd Foundation in 2001, Havelin was the Associate Director of Development for the Liberty Hill Foundation, supporting grass roots organizing projects in Los Angeles. Prior to her involvement with the philanthropic community, she worked as an organizer and fundraiser for Planned Parenthood Los Angeles, theCalifornia Abortion Rights Action League, and the California League of Conservation Voters.
Melanie was voted to the board in October of 2006.
Shane Jenkins serves in the dual capacity of both Director of HIV/AIDS Initiative and Director of Social Efforts at the Magic Johnson Foundation, where she has an impressive 11 year professional history of program management.
In the capacity of the Director of HIV/AIDS Initiative, Shane is responsible for leading the program which launched the Magic Johnson Foundation in 1991. She is responsible for all operational aspects of programming which includes grant making to HIV/AIDS organization, managing partnerships with AIDS Healthcare Foundation, community based organizations, volunteers and corporate partners such as Aetna, Abbott Laboratories and GlaxoSmithKline. Shane also is responsible for managing the national “I Stand with Magic” campaign which resulted in 111 million media impressions. Additionally, grassroots efforts reached more than 600,00 individuals and 80,000 HIV tests were administered.
Shane’s true passion for helping others has proven to be the key ingredient for success in her duties as Director of Social Efforts. In this capacity she works as a champion to provide socially and economically disadvantaged youth access to entertainment and social activities that would not otherwise be available. For 11 of 14 years, Shane has been responsible for coordinating the Kid’s Mardi Gras Gala which provides inner city youth free access to a fun filled day of food, fun, entertainment, games and prizes in a carnival setting. Additionally she is responsible for coordinating the Annual Holiday Party which brings holiday cheer to families in need. Shane’s social program efforts have made a positive contribution to the lives of over 25,000 thousand youth. Shane was voted to the Board of Directors in November 2011.
Michael N. Joyner is Director, Positive Action, the global HIV and AIDS programme supported by ViiV Healthcare. The Positive Action programme initiatives are community-based and focus on the key populations most vulnerable to HIV disease, including girls and women, commercial sex workers, injecting drug users, the incarcerated, MSM, transgender and gay men.
Support from the Positive Action programme is based on one or more of the following criteria: delivering greater and meaningful involvement of people living with HIV, building capacity in grassroots communities, preventing HIV, tackling stigma and discrimination, and testing innovations in education, care and treatment. Michael works with partners around the globe and provides technical assistance and funding to help them meet project deliverables and milestones.
In 2009 Michael led the transition of the Positive Action programme from GlaxoSmithKline to ViiV Healthcare: the new joint venture between GlaxoSmithKline and Pfizer. In addition, he was a member of the internal team that created the founding principles for the newly established £50 million Positive Action for Children Fund. His work at ViiV Healthcare includes collaborations with the ViiV corporate team and local operating companies to provide leadership and understanding of HIV and AIDS issues and share best practices of community engagement and support.
Prior to directing the Positive Action programme, Michael served as the architect of the HIV treatment advocacy programme for GlaxoSmithKline in the U.S. During this tenure, he created the nationally recognized Summer Summit on HIV, which facilitated an exchange of scientific information about advances in HIV treatment between company scientists, external experts, and HIV community advocates, including treatment educators and thought leaders from US-based AIDS Service Organizations. Michael graduated from the University of North Carolina at Chapel Hill with a degree in Biology. He has served as an Advisory Board Member for CDC’s Business Responds to AIDS/Labor Responds to AIDS Programme. Michael was voted to the Board in December 2010.
Appointed President/CEO of the AIDS Foundation of Chicago (AFC) in November 2010, David Ernesto Munar brings to his work more than two decades of accomplishment fighting HIV/AIDS. Prior to his current appointment, he served as the organization’s vice president with oversight and management of a $16 million portfolio of HIV-related programs and services. He joined AFC in 1991 and has held senior management positions over programs, policy and communications since 1998. In 2007, Mr. Munar helped launch the Coalition for a National AIDS Strategy, which lead to the National HIV/AIDS Strategy unveiled by President Obama in July 2010. He has served on numerous advisory boards for the U.S. Centers for Disease Control and Prevention, Health Resources Services Administration, and the National Institute of Allergy and Infectious Diseases. He currently serves on the Illinois AIDS Drug Assistance Program Advisory Board, the Illinois Intergovernmental HIV/AIDS Task Force, the Pediatric AIDS Chicago Prevention Initiative Board of Directors, and AIDS United’s Policy Committee. At the 2010 International AIDS Conference, Mr. Munar represented the U.S. on a regional panel for Canada and the United States. He was a plenary speaker at the 2009 National HIV Prevention Conference; the 2009 Creating Change National Conference on LGBT Equality; the Global AIDS Alliance’s 2008 National Democratic Convention luncheon; and co‐moderated with Congresswoman Barbara Lee (D‐CA) a session at the 2008 International AIDS Conference. The International AIDS Society selected Munar to serve on the 2012 International AIDS Conference Coordinating Committee and POZ Magazine named Munar as one of its 100 most influential AIDS advocates of 2010. In 2010, Munar was inducted into the City of Chicago Gay and Lesbian Hall of Fame. Beyond his professional experience, Munar draws on his perspectives as a bilingual Colombian‐American and gay man living with HIV. He is a graduate of Northwestern University. David was elected to the Board in November 2011.
Shari Turitz became director of programs in the Public Health Program at the Open Society Foundations in January 2008. From 1997-2007 she worked at the Synergos Institute, where she ran a global program to build philanthropy and foundations in Asia, Africa, and Latin America.
Prior to that she was deputy director of the Guatemala Human Rights Commission/USA, consulted to the Covenant House Latin America programs, and worked for the UNICEF NGO Committee on Exploited Children, where she researched and wrote a report on global NGO initiatives on child labor. Turitz holds a BA in political science and Latin American studies from Tufts Univers. Shari was voted to the Board of Directors in November 2011.
Photo courtesy of Open Society Foundations